Markus Winkler
We speak with esteemed chronic pain patient advocate, Dr. Richard “Red” Lawhern, to seek endorsements for his formal complaint against the authors of the Centers for Disease Control and Prevention Opioid Prescribing Guidelines.
#CDC #DEA #DOJ #opioids #misinformation #disinformation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more
